September 14, 2020 Comments Off on New patent for Global Blood drug OXBRYTA Posted in: Patent Added Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are six patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugPat…
September 14, 2020 Comments Off on New patent for Helsinn Hlthcare drug AKYNZEO Posted in: Patent Added Annual Drug Patent Expirations for AKYNZEO Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from one supplier. There are fifteen patents…
The post New patent for Helsinn Hlthcare drug AKYNZEO appeared first on…